| Bid Price | 141.00p | High Price | 158.50p |
|---|
| Ask Price | 144.00p | Low Price | 142.46p |
|---|
| Open Price | 150.00p | Spread | 2.08% |
|---|
| Prev Close | 154.25p | Volume | 56,419 |
|---|
Hemogenyx Pharmaceuticals PLC Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Aug 4, 2025 | 150.00 | 158.50 | 142.46 | 142.50 | 56,419 |
| Aug 1, 2025 | 154.60 | 157.50 | 150.38 | 154.25 | 14,284 |
| Jul 31, 2025 | 159.50 | 159.50 | 152.50 | 155.50 | 3,165 |
| Jul 30, 2025 | 158.03 | 159.50 | 152.85 | 156.75 | 3,718 |
| Jul 29, 2025 | 166.00 | 174.50 | 152.50 | 156.75 | 65,174 |
Hemogenyx Pharmaceuticals PLC Information
| Name | Hemogenyx Pharmaceuticals PLC | Index | |
|---|
| ISIN | GB00BQVXM815 | Epic | HEMO |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | SET3 |
|---|
| Industry | Biotechnology | Sector | Healthcare |
|---|
| EMS | 1,500 | Trading Status | Closed |
|---|
| Shares in Issue | 4.59 m | Prev Close | 154.25p |
|---|
| PE Ratio | | Market Cap | £6.55 m |
|---|
| Div Yield | 0 | Div per Share | £NaN |
|---|
| EPS | -£1.01 | Div Cover | NaN |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | -0.572635 | DPS Growth (%) | 0 |
|---|
| Current Ratio | 0.724158 | Quick Ratio | 0.140709 |
|---|
Hemogenyx Pharmaceuticals PLC Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 13/06/25 | PLAC | Vladislav Sandler | CEO | 250,000 @ £1.81 | £451,250.00 |
| 14/05/25 | PLAC | Vladislav Sandler | CEO | 250,000 @ £1.81 | £451,250.00 |
| 30/01/20 | PLAC | Peter Redmond | NED | 555,556 @ £0.02 | £10,000.00 |
| 03/07/19 | TIN | Vladislav Sandler | CEO | 1,066,667 @ £0.00 | £0.00 |
| 12/02/18 | BUY | Adrian Thorpe Beeston | RES | 200,000 @ £0.02 | £4,200.00 |
| 07/02/18 | BUY | Vladislav Sandler | CEO | 26,800 @ £0.02 | £635.00 |
| 11/10/17 | BUY | Adrian Thorpe Beeston | RES | 400,000 @ £0.03 | £11,840.00 |
| 10/10/17 | BUY | Peter Redmond | NED | 155,000 @ £0.03 | £4,859.00 |
| 10/10/17 | BUY | Adrian Thorpe Beeston | RES | 317,683 @ £0.03 | £9,848.00 |
Hemogenyx Pharmaceuticals PLC News
